#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cortical dysplasia Activated PI3 kinase delta syndrome Hepatocellular carcinoma Friedreich's ataxia Meningitis meningococcal Thrombotic thrombocytopenic purpura Hypophosphatasia Inflammatory myofibroblastic tumour Oesophageal achalasia Meningococcal immunisation Hereditary hypophosphataemic rickets Non-small cell lung cancer metastatic Becker's muscular dystrophy Soft tissue sarcoma Erythema More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Diagnostics Nephroblastoma – Treatment Nephroblastoma Immunodeficiency congenital Rosai-Dorfman syndrome – Diagnostics Alternating hemiplegia of childhood – Life with Disease Langerhans cell sarcoma – Treatment Mantle cell lymphoma stage III – Trials in Disease Alagille syndrome – Diagnostics Alexander disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cetirizine Zipalertinib Salbutamol Calcium Folinate Pentahydrate Bupivacaine Hydrochloride Sibeprenlimab 177LU-FAP-2286 Valine Bortezomib Eftrenonacog Alfa Ixekizumab Ketoprofen Lysine Festuca Rubra Pollen ALLO-QUADCAR01-T Dabigatran Streptococcus Pneumoniae Abbv-668 Lt3001 Tiotropium Dsimc More therapies…

    Learn about Your Condition

    Hydrocele Diabetes mellitus Rasmussen encephalitis Urticaria cholinergic Toxic epidermal necrolysis Aortic valve stenosis Affective disorder Insulin resistance Dermatitis Mucopolysaccharidosis II Colorectal cancer Bile acid synthesis disorder Graft infection Marginal zone lymphoma Thermal burn More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Levoleucovorin
    • Irinotecan Hydrochloride Trihydrate
    • Capecitabine
    France

  • Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Trastuzumab Emtansine
    Belgium Czechia Denmark France Germany Greece +7

  • Study on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Pralsetinib
    • Alectinib
    • Entrectinib
    Belgium Denmark France Germany Italy Poland +2

  • Study on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Laryngeal squamous cell carcinoma
    • Squamous cell carcinoma of the hypopharynx
    Investigated Drugs:
    • Cisplatin
    • Docetaxel
    • Fluorouracil
    France

  • Study on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Vemurafenib
    France

  • Study on the Safety and Effectiveness of ABSK021 for Patients with Tenosynovial Giant Cell Tumor

    Not recruiting

    3 1
    Investigated Diseases:
    • Giant cell tumour of tendon sheath
    Investigated Drugs:
    • Absk021 Hydrochloride Hydrate
    France Italy The Netherlands Poland Spain

  • Study of Volrustomig for Patients with Advanced Solid Tumors with Mature Tertiary Lymphoid Structures

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Volrustomig
    France

  • Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Doxorubicin Hydrochloride, Liposomal
    • Capecitabine
    • Doxorubicin
    Austria France Germany Greece Hungary Ireland +7

  • Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Doxorubicin
    • Paclitaxel
    • Pembrolizumab
    Belgium France Germany Hungary Ireland Poland +2

  • Study of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    France Germany Ireland Italy Poland Spain
Previous Page
1 … 22 23 24 25 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!